Camelids, such as camel and llama, produce two types of nan-canonical antibodies, conventional IgG1, IgG2, and IgG3. They’re all heavy-chain IGs. They all have one domain binding portion, VHH, and lack a CH1 domain or light chains.
They consist of passive
structures that make them useful in medical trials and cancer research,
diagnostics, and treatments.
Why use goat anti-llama
Alkaline Phosphatase for VHH discovery?
To expand and quicken VHH
antibodies, researchers have suggested using goat anti-llama HRP.
VHH IGs are the result of heavy chain goat anti-llama Alkaline phosphatase VHH domain. The bodies, also called nanobodies, are now often used in various fields due to the benefits they provide.
VHH antibody applications
include medical diagnostics, therapeutics, crystallization partners, small
molecule detections and biosensors.
What are the benefits of
goat anti-llama HRP-derived VHH antibodies?
VHH antibodies are stable,
allowing them to travel through an organism. The antibodies offer solubility.
They can withstand heat as well.
Therapeutic: VHH antibodies
cross the blood-brain barrier to reach isolated channels that make drug
delivery more efficient. The delivery can occur via various methods such as IV,
inhalation, and ingestion.
Goat anti-llama alkaline
phosphatase for VHH Discovery can be
obtained from companies like www.capralogisc.com.
No comments:
Post a Comment